Apogee Therapeutics Inc (APGE)
EBITDA Growth
-22.86%
TTM · Period ending:
APGE EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-22.86%period ending
Latest reported-22.86%period ending
APGE TTM EBITDA YoY % (-274.40% → -22.86%)
Year-over-year change
High-resolution chart · PNG
APGE ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -22.8561% | |
| -33.0851% | |
| -39.688% | |
| -72.1952% | |
| -99.9392% | |
| -142.1113% | |
| -246.9338% | |
| -322.164% | |
| -753.539% | |
| -510.062% | |
| -274.3985% |